Wednesday, 28th of May 2008
This program is permanently updated according to the answers of the solicited speakers.
Sessions of the day : Heart, laminopathies and dystrophinopathies
morning Session : heart |
|
| 8h30 9h15 |
|
|---|---|
| 9h15 10h00 |
|
| 10h00 10h30 |
|
| 10h30 12h00 |
|
“Fundamental aspects of heart development” (Amphithéâtre Callelongue)Chairpersons : Joël Nargeot and Jean Jacques Schott Michel Pucéat (France) : Cardiac commitment of human embryonic stems cells : towards the generation of cardiac progenitors for cell therapy of heart failure Bernard K. Fleischmann (Germany) : The potential and pitfalls of cell replacement strategies in the heart Robert G. Kelly (France) : Myocardial progenitor cells in early embryo |
|
“Cardiomyopathies and experimental models” (Salle Endoume)Chairpersons : Denise Paulin and Urs Ruegg Gisèle Bonne (France) : Animal models in laminopathies Angelo Parini (France) : Animal models of cardiac cell therapy : how and why Christelle Monville (France) : An in vitro beating heart model for functional assessment of pharmacological compounds and cell therapy |
|
“Cell or pharmacotherapy of cardiomyopathy” (Auditorium)Chairpersons : Yves Fromes and Michel Villaz Patricia Le Marchand (France) : Cardiac cell therapy : clinical trials Jean-Thomas Vilquin (France) : Myoblast transplantation in heart failure : the MAGIC study Christine Mummery (The Netherlands) : Cardiomyocytes from human embryonic stem cells and cardiac regeneration |
|
| 12h00 13h00 |
|
plenary lecture (auditorium)
Break
parallel symposia 
lunch break| 13h00 14h30 |
|
|---|
afternoon sessions : laminopathies and dystrophinopathies |
|
| 14h30 15h15 |
|
|---|---|
| 15h15 16h00 |
|
| 16h00 16h30 |
|
| 16h30 17h30 |
|
"New insight in laminopathies" (Amphithéâtre Callelongue)Chairpersons : Gisèle Bonne and John Vissing Howard J. Worman (canada) : MAP Kinase signalling and cardiomyopathy in Emery-Dreifuss muscular dystrophy Chris Hutchison (UK) : Novel functions of emerin in cytoskeleton organisation and gene regulation Roland Foisner (Austria) : Nucleoplasmic lamin complexes regulate muscle progenitor cells |
|
"New approaches to the therapy of dystrophinopathies" (Auditorium)Chairpersons : Mireille Claustres and Jean-Claude Kaplan Yvan Torrente (Italy) : Autologous transplantation of engineered muscle-derived CD133+ stem cells Jamel Chelly (France) : Molecular diagnosis and ex-vivo validation of therapeutic approaches in dystrophinopathies Isabelle Richard (France) : Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation |
|
"Innovativ approaches to therapy" (salle Endoume)Chairpersons : François Rivier et Philippe Gailly Vincenzo Nigro (Italy) : Systemic delta-sarcoglycan gene delevery avoids life long evolution of cardiomyopathy and muscular dystrophy of Bio 14.6 hamster Alessandra Ferlini (Italy) : The systemic administration of a low dose of 20M2ePS-AON combinated with novel cationic polymethyl mathacrylate nanoparticles induce the rescue of dystrophin expression in both cardiac and skeletal muscle in mdx murine model Philippe Moullier (France) : Adeno-associated viral vector genomes persist as episomal chromatin in primate skeletal muscle |
|
| 17h30 18h30 |
|
| 19h00 20h00 |
|
